Role of SFRP5 in Non-Small Cell Lung Cancer and Its Correlation with SUV of 18F-FDG PET-CT

被引:0
|
作者
Zhang, Na [1 ]
Bai, Tian [1 ]
Jiang, Yunfei [2 ]
Zhu, Kun [3 ]
Yao, Lan [4 ]
Ji, Jia [5 ]
Huang, Qicheng [1 ]
机构
[1] Qiqihar Med Univ, Affiliated Hosp 3, Radiog Imaging Ctr, Qiqihar, Peoples R China
[2] Qiqihar Med Univ, Affiliated Hosp 3, Resp Dept, Qiqihar, Peoples R China
[3] Qiqihar Med Univ, Affiliated Hosp 3, Cardiothorac Surg Dept, Qiqihar, Peoples R China
[4] Qiqihar Med Univ, Affiliated Hosp 3, Nucl Med Dept, Qiqihar, Peoples R China
[5] Qiqihar Med Univ, Affiliated Hosp 3, Stomatol Dept, Qiqihar, Peoples R China
关键词
SFRP5; non-small cell lung cancer; 18F-FDG PET-CT; cell proliferation; cell metastasis; WNT; EXPRESSION; MUTATION; MARKERS;
D O I
10.1080/08941939.2024.2381722
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim: This study aimed to evaluate the relationship between secreted frizzled-related protein 5 (SFRP5) expression and fluorine 18-fluoro-deoxyglucose (18 F-FDG) uptake imaged with positron emission tomography/tomography (PET/CT) in patients with non-small cell lung cancer (NSCLC). In addition, we sought to elucidate the potential role and mechanism of action of SFRP5 in NSCLC.Materials and methods: The maximum standardized uptake value (SUVmax) of the lesions was calculated. SFRP5 expression was analyzed using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). The correlation between SFRP5 expression and SUVmax was evaluated using Pearson's correlation analysis. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), flow cytometry, wound healing, and transwell assays were used to analyze cell viability, apoptosis, migration, and invasion, respectively.Results and conclusion: The results indicated that the SUVmax was higher in patients with NSCLC than that in healthy volunteers. Moreover, SFRP5 expression was lower in tissues from the four types of NSCLC than that in the adjacent normal tissues. SUVmax negatively correlated with SFRP5 expression in the four types of NSCLC. In addition, up-regulation of SFRP5 decreased the viability, migration, and invasion abilities, and increased apoptosis of NSCLC cells. Furthermore, SFRP5 inhibited the Wnt/beta-catenin pathway in NSCLC cells. In conclusion, SFRP5 modulates the biological behaviors of NSCLC through Wnt/beta-catenin pathway.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Prognostic role of baseline 18F-FDG pet/CT in stage I and stage ii non-small cell lung cancer
    Dondi, Francesco
    Albano, Domenico
    Bellini, Pietro
    Cerudelli, Elisabetta
    Treglia, Giorgio
    Bertagna, Francesco
    [J]. CLINICAL IMAGING, 2023, 94 (71-78) : 71 - 78
  • [32] Role of (18)FDG-PET/CT and SUV evaluation in the management of Non-Small Cell Lung Cancer in different stages
    Cistaro, A.
    Quartuccio, N.
    Rimicci, A.
    Fania, P.
    Ficola, U.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S424 - S424
  • [33] Hyperprogressive Disease in Patients with Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of 18F-FDG PET/CT
    Castello, Angelo
    Rossi, Sabrina
    Mazziotti, Emanuela
    Toschi, Luca
    Lopci, Egesta
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (06) : 821 - 826
  • [34] The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC)
    Silvia Morbelli
    Maria Lucia Calcagni
    Angelina Cistaro
    Mohsen Farsad
    Luca Guerra
    Cristina Nanni
    Andrea Bianchi
    [J]. Clinical and Translational Imaging, 2020, 8 : 29 - 38
  • [35] The need of a clinically oriented reporting of 18F-FDG PET/CT in non-small cell lung cancer (NSCLC)
    Morbelli, Silvia
    Calcagni, Maria Lucia
    Cistaro, Angelina
    Farsad, Mohsen
    Guerra, Luca
    Nanni, Cristina
    Bianchi, Andrea
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2020, 8 (01) : 29 - 38
  • [36] Benign foci in the mediastinum or hilum in non-small cell lung cancer: Description on 18F-FDG PET/CT
    Kang, Ji Yeon
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [37] Potentials of Non-Invasive 18F-FDG PET/CT in Immunotherapy Prediction for Non-Small Cell Lung Cancer
    Liao, Xuhe
    Liu, Meng
    Wang, Rongfu
    Zhang, Jianhua
    [J]. FRONTIERS IN GENETICS, 2022, 12
  • [38] 18F-FDG PET/CT detects seldom and rare sites of metastasis of non-small cell lung cancer
    Ren, Shu
    Zhao, Jun
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [39] 18F-FDG PET/CT Evaluation of Non-Small Cell Lung Cancer Initial Experience from Johannesburg
    Evbuomwan, Osayande
    Ayeni, Olusegun A.
    Purbhoo, Khushica
    Vangu, Mboyo D. T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S495 - S495
  • [40] Integrated 18F-FDG PET/CT parameter defines metabolic oligometastatic non-small cell lung cancer
    Ma, Rong
    Zhao, Qian
    Zhao, Ren
    Li, Juan
    Wang, Yan-Yang
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (09) : 1026 - 1033